VS-4718

· Verastem, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VS-4718, covering 2017-07-27 to 2017-07-28. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Dose Escalation Study of VS-4718 in Subjects With Metastatic Non-Hematologic Malignancies [Phase 1]